@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/datacite/> .
@prefix ns2: <http://purl.org/vocab/frbr/core#> .
@prefix ns3: <http://purl.org/spar/pro/> .
@prefix ns4: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/0630887930> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 0630887930" ;
    ns4:publicationDate "2019-09-12"^^xsd:date ;
    dcterms:title "Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature In Vitro Activity Profiles? A Case Study Of AMB-FUBINACA" ;
    ns1:hasIdentifier <https://w3id.org/oc/meta/id/06104741499>,
        <https://w3id.org/oc/meta/id/0630939786>,
        <https://w3id.org/oc/meta/id/0677075827> ;
    ns3:isDocumentContextFor <https://w3id.org/oc/meta/ar/06303804084>,
        <https://w3id.org/oc/meta/ar/06303804085>,
        <https://w3id.org/oc/meta/ar/06303804086>,
        <https://w3id.org/oc/meta/ar/06303804087>,
        <https://w3id.org/oc/meta/ar/06303804088>,
        <https://w3id.org/oc/meta/ar/06303804089>,
        <https://w3id.org/oc/meta/ar/06303804090>,
        <https://w3id.org/oc/meta/ar/06303804091>,
        <https://w3id.org/oc/meta/ar/06303804092> ;
    ns2:embodiment <https://w3id.org/oc/meta/re/0630683331> ;
    ns2:partOf <https://w3id.org/oc/meta/br/0630888855> .